4//SEC Filing
Kowalsky Matthew Paul 4
Accession 0001415889-23-003686
CIK 0001821323other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:46 PM ET
Size
5.4 KB
Accession
0001415889-23-003686
Insider Transaction Report
Form 4
Kowalsky Matthew Paul
CHIEF OF STAFF AND CLO
Transactions
- Award
Stock Option (Right to Buy)
2023-02-28+165,000→ 165,000 totalExercise: $1.09Exp: 2033-02-27→ Common Stock (165,000 underlying)
Footnotes (1)
- [F1]The options vest as to 25% of the underlying shares of common stock on February 28, 2024, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each quarter following such date until the options are fully vested.
Documents
Issuer
Sigilon Therapeutics, Inc.
CIK 0001821323
Entity typeother
Related Parties
1- filerCIK 0001705824
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:46 PM ET
- Size
- 5.4 KB